Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Amphastar Pharmaceuticals ( (AMPH) ) has shared an update.
On March 12, 2026, Amphastar Pharmaceuticals’ board authorized a $50 million increase to its share buyback program, extending a capital allocation strategy aimed at managing its equity structure over an indefinite period. The program is designed primarily to offset dilution from equity compensation, with repurchases to be executed through open-market purchases, private block trades, Rule 10b5-1 plans, or other negotiated transactions, and the pace of buybacks will depend on share price, corporate needs, regulatory considerations, and broader market conditions.
The most recent analyst rating on (AMPH) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on Amphastar Pharmaceuticals stock, see the AMPH Stock Forecast page.
Spark’s Take on AMPH Stock
According to Spark, TipRanks’ AI Analyst, AMPH is a Neutral.
The score is held back primarily by weakening near-term fundamentals (TTM revenue and margin reset) and especially weak/unclear TTM cash flow, alongside very bearish technicals (price far below major moving averages with negative momentum). These risks are partially offset by a reasonable P/E valuation and a cautiously positive outlook from the latest earnings call (2026 growth guidance and a near-term exclusive launch), with corporate actions modestly supportive.
To see Spark’s full report on AMPH stock, click here.
More about Amphastar Pharmaceuticals
Amphastar Pharmaceuticals operates in the pharmaceutical industry, focusing on the development, manufacture, and distribution of injectable, inhalation, and intranasal products, including both generic and proprietary specialty pharmaceuticals. The company primarily targets hospital, emergency, and critical-care settings, as well as retail and specialty pharmacy markets in the United States and abroad.
Average Trading Volume: 446,290
Technical Sentiment Signal: Sell
Current Market Cap: $824.8M
Learn more about AMPH stock on TipRanks’ Stock Analysis page.